An Epidemiologic Study on PD-L1 Expression Combined With Clinical Observation in the Chinese MIUBC Patients.

Clinical trial NCT03433924 · COMPLETED

Trial details

NCT number: NCT03433924
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Urinary Bladder Cancer

Start date: 2020-05-18
Primary completion: 2023-03-27
Enrollment: 248

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.